InvestorsHub Logo
Followers 17
Posts 812
Boards Moderated 0
Alias Born 02/21/2011

Re: None

Friday, 11/01/2013 9:26:09 AM

Friday, November 01, 2013 9:26:09 AM

Post# of 2191
LCS
InPlay: Zalicus announces positive results of Z944 Phase 1b clinical study in pain; efficacy signals in inflammatory and neuropathic pain observed; second U.S. patent issues for Z944 providing exclusivity to 2029 Briefing.c